Cargando…
Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma
Inhibitors of the mitotic kinesin Kif11 are anti-mitotics that, unlike vinca alkaloids or taxanes, do not disrupt microtubules and are not neurotoxic. However, development of resistance has limited their clinical utility. While resistance to Kif11 inhibitors in other cell types is due to mechanisms...
Autores principales: | Kenchappa, Rajappa S., Dovas, Athanassios, Argenziano, Michael G., Meyer, Christian T., Stopfer, Lauren E., Banu, Matei A., Pereira, Brianna, Griffith, Jessica, Mohammad, Afroz, Talele, Surabhi, Haddock, Ashley, Zarco, Natanael, Elmquist, William, White, Forest, Quaranta, Vito, Sims, Peter, Canoll, Peter, Rosenfeld, Steven S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018805/ https://www.ncbi.nlm.nih.gov/pubmed/35732128 http://dx.doi.org/10.1016/j.celrep.2022.110991 |
Ejemplares similares
-
Multiplexed single-cell lineage tracing of mitotic kinesin inhibitor resistance in glioblastoma
por: Cheng, Yim Ling, et al.
Publicado: (2023) -
Protein kinase C(ι) and SRC signaling define reciprocally related subgroups of glioblastoma with distinct therapeutic vulnerabilities
por: Kenchappa, Rajappa S., et al.
Publicado: (2021) -
Myosin 10 Regulates Invasion, Mitosis, and Metabolic Signaling in Glioblastoma
por: Kenchappa, Rajappa S., et al.
Publicado: (2020) -
Deconvolution of cell type-specific drug responses in human tumor tissue with single-cell RNA-seq
por: Zhao, Wenting, et al.
Publicado: (2021) -
Enhancing Brain Retention of a KIF11 Inhibitor Significantly Improves its Efficacy in a Mouse Model of Glioblastoma
por: Gampa, Gautham, et al.
Publicado: (2020)